Drug Approval | August 16, 2023
Eugia Pharma receives USFDA Approval for Icatibant Injection
This is the 166th ANDA out of Eugia Pharma Speciality Group facilities
This is the 166th ANDA out of Eugia Pharma Speciality Group facilities
The product is being launched in August 2023
Merck continues progress in helping to protect people at risk of Zaire ebolavirus disease
Take proper precautions and seek timely treatment!
The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted by AstraZeneca
Apollo Transplant program is the first program in India to cross the landmark of 18500 kidney transplants, 4300 liver transplants and 500 pediatric liver transplants
The CHMP’s recommendation will now be reviewed by the European Commission for marketing authorization in the European Union
If approved, KEYTRUDA would be the first immunotherapy for the first-line treatment of HER2-positive advanced gastric or GEJ cancer in tumors expressing PD-L1 (CPS ?1) in the EU
Luforbec® 100/6 pMDI aims to provide comprehensive support to patients and healthcare professionals
The strategic acquisition demonstrates the company’s commitment to increasing OTC consumer convenience in eye care
Subscribe To Our Newsletter & Stay Updated
